adenosine diphosphate ribose has been researched along with Pulmonary Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akgün, AE; Dodurga, Y; Seçme, M; Şenol, H; Yaylalı, YT | 1 |
| Dipp, M; Evans, AM | 1 |
2 other study(ies) available for adenosine diphosphate ribose and Pulmonary Hypertension
| Article | Year |
|---|---|
Kynurenine-PARP-1 Link Mediated by MicroRNA 210 May Be Dysregulated in Pulmonary Hypertension.
Topics: Adenosine Diphosphate Ribose; Apelin; Humans; Hypertension, Pulmonary; Hypoxia; Kynurenine; MicroRNAs; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Prospective Studies; RNA, Messenger | 2022 |
Cyclic ADP-ribose is the primary trigger for hypoxic pulmonary vasoconstriction in the rat lung in situ.
Topics: Adenosine Diphosphate Ribose; Animals; Caffeine; Cell Hypoxia; Culture Techniques; Cyclic ADP-Ribose; Dose-Response Relationship, Drug; Hypertension, Pulmonary; Indoles; Kinetics; Lung; Male; Pulmonary Artery; Rats; Rats, Wistar; Ryanodine; Vasoconstriction | 2001 |